13F-HR filed by Exome Asset Management LLC
Exome Asset Management LLC filed this 13F-HR for the quarter ended 2026-09-30, accepted by EDGAR 2026-11-16 14:10:47 UTC, with 55 holding rows worth $153,028,952.
- Accession
- 0001420506-26-002739
- Filer
- CIK 2011932
- Filed
- 2026-11-16
- Accepted by EDGAR
- Ingested
- Source
- EDGAR live feed
13F report for Q3 2026
A holdings report, 55 entries on the cover page, a total value of $153,028,952 stated on the cover page (in dollars after the unit check, H1), rows summing to $153,028,952 with VALUE read as dollars as filed, 13F file number 028-23951. The quarter's positions are built on this report. The resolved quarter.
The information table after summing rows of one CUSIP and put or call (H4), with the CUSIP and issuer name as filed. Values in dollars after the unit check (method).
| Issuer as filed | CUSIP | Class | Amount | Value | Value read as | Type |
|---|---|---|---|---|---|---|
| GUARDANT HEALTH INC COM | 40131M109 | Stock | 67,500 | $12,039,300 | dollars as filed | |
| TG THERAPEUTICS INC COM | 88322Q108 | Stock | 187,671 | $10,468,288 | dollars as filed | |
| ABIVAX SA- | 00370M103 | SPONSORED ADS | 90,919 | $9,002,799 | dollars as filed | |
| PRAXIS PRECISION MEDICINES I | 74006W207 | COM NEW | 29,681 | $8,643,998 | dollars as filed | |
| COGENT BIOSCIENCES INC | 19240Q201 | COM | 210,523 | $6,740,946 | dollars as filed | |
| Eli Lilly and Company | 532457108 | COM | 5,492 | $6,354,683 | dollars as filed | |
| NATERA INC COM | 632307104 | Stock | 13,800 | $5,703,678 | dollars as filed | |
| VERA THERAPEUTICS INC | 92337R101 | COMMON STOCK | 159,556 | $5,152,063 | dollars as filed | |
| VIKING THERAPEUTICS INC | 92686J106 | COM | 147,497 | $4,808,402 | dollars as filed | |
| IONIS PHARMACEUTICALS INC COM | 462222100 | Stock | 107,034 | $4,779,068 | dollars as filed | |
| ENLIVEN THERAPEUTICS INC COM | 29337E102 | Stock | 100,203 | $4,593,306 | dollars as filed | |
| CARIS LIFE SCIENCES INC | 142152107 | COMMON STOCK | 146,093 | $4,474,829 | dollars as filed | |
| NEKTAR THERAPEUTICS | 640268306 | COMMON STOCK | 73,708 | $4,462,651 | dollars as filed | |
| CYTOKINETICS INC | 23282W605 | COM NEW | 60,056 | $3,958,291 | dollars as filed | |
| VERASTEM INC | 92337C203 | COMMON STOCK | 429,041 | $3,453,780 | dollars as filed | |
| MAZE THERAPEUTICS INC COM | 578784100 | Stock | 114,692 | $3,117,329 | dollars as filed | |
| RHYTHM PHARMACEUTICALS INC | 76243J105 | COM | 32,209 | $3,066,780 | dollars as filed | |
| 10X GENOMICS INC CL A COM | 88025U109 | Stock | 30,074 | $2,717,487 | dollars as filed | |
| ALKERMES PLC | G01767105 | SHS | 61,336 | $2,485,335 | dollars as filed | |
| UNITED THERAPEUTICS CORP DEL COM | 91307C102 | Stock | 4,109 | $2,226,626 | dollars as filed | |
| Boston Scientific Corporation | 101137107 | COM | 48,347 | $2,110,347 | dollars as filed | |
| ARROWHEAD PHARMACEUTICALS IN | 04280A100 | COM | 32,214 | $2,108,406 | dollars as filed | |
| UnitedHealth Group Inc | 91324P102 | COM | 5,697 | $2,091,255 | dollars as filed | |
| OCULAR THERAPEUTIX INC | 67576A100 | COM | 272,046 | $2,086,593 | dollars as filed | |
| ALUMIS INC | 022307102 | COM | 282,253 | $2,085,850 | dollars as filed | |
| PENUMBRA INC COM | 70975L107 | Stock | 6,300 | $2,005,542 | dollars as filed | |
| Intuitive Surgical,Inc. | 46120E602 | COM | 4,908 | $1,995,740 | dollars as filed | |
| MOONLAKE IMMUNOTHERAPEUTICS CLASS A ORD | 61559X104 | Stock | 166,493 | $1,947,968 | dollars as filed | |
| COMPASS PATHWAYS PLC | 20451W101 | SPONSORED ADS | 153,087 | $1,904,402 | dollars as filed | |
| CELLDEX THERAPEUTICS INC NEW | 15117B202 | COM NEW | 56,269 | $1,823,678 | dollars as filed | |
| Merck & Co.,Inc. | 58933Y105 | COM | 12,358 | $1,795,741 | dollars as filed | |
| LIQUIDIA CORPORATION COM NEW | 53635D202 | Stock | 59,155 | $1,790,030 | dollars as filed | |
| GLAUKOS CORP COM | 377322102 | Stock | 10,862 | $1,783,432 | dollars as filed | |
| MONTE ROSA THERAPEUTICS INC | 61225M102 | COM | 137,015 | $1,634,589 | dollars as filed | |
| BRIDGEBIO PHARMA INC | 10806X102 | COM | 21,209 | $1,395,552 | dollars as filed | |
| CLEARPOINT NEURO INC | 18507C103 | COM | 110,174 | $1,345,225 | dollars as filed | |
| CORBUS PHARMACEUTICALS | 21833P301 | COM NEW | 190,714 | $1,300,669 | dollars as filed | |
| CYTOMX THERAPEUTICS INC | 23284F105 | COMMON STOCK | 460,067 | $1,251,382 | dollars as filed | |
| PALVELLA THERAPEUTICS INC | 697947109 | COMMON STOCK | 7,809 | $1,077,095 | dollars as filed | |
| ASCENDIS PHARMA A/S | K08588103 | ORD SHS *A* | 4,414 | $1,005,642 | dollars as filed | |
| RAPPORT THERAPEUTICS INC COM | 75383L102 | Stock | 29,381 | $987,202 | dollars as filed | |
| BILLIONTOONE INC | 090168105 | CL A | 8,983 | $956,151 | dollars as filed | |
| ZENAS BIOPHARMA INC COM | 98937L105 | Stock | 34,341 | $926,177 | dollars as filed | |
| REPLIMUNE GROUP INC | 76029N106 | COMMON STOCK | 68,488 | $906,781 | dollars as filed | |
| EQUILLIUM INC | 29446K106 | COM | 552,956 | $898,554 | dollars as filed | |
| ESTABLISHMENT LABS HOLDINGS | G31249108 | COMMON STOCK | 13,100 | $840,627 | dollars as filed | |
| CLIMB BIO INC | 28658R106 | COMMON STOCK | 71,215 | $816,836 | dollars as filed | |
| NOVABRIDGE BIOSCIENCES | 44975P103 | CMN | 576,960 | $787,550 | dollars as filed | |
| BRIGHT MINDS BIOSCIENCES INC | 10919W405 | COMMON STOCK | 14,715 | $733,101 | dollars as filed | |
| COMPASS THERAPEUTICS INC | 20454B104 | COM | 511,084 | $531,527 | dollars as filed | |
| Q32 BIO INC | 746964105 | Common Stock | 62,589 | $517,611 | dollars as filed | |
| CAPRICOR THERAPEUTICS INC | 14070B309 | COMMON STOCK | 51,531 | $487,999 | dollars as filed | |
| UNIQURE NV | N90064101 | SHS | 18,300 | $442,128 | dollars as filed | |
| Arbutus Biopharma Corp | 03879J100 | Common Shares, without par value | 50,166 | $239,793 | dollars as filed | |
| ADAGENE INC | 005329107 | CMN | 52,543 | $168,138 | dollars as filed |
Amendment chain
| Filing | Role | Filed | Accepted | Ingested |
|---|---|---|---|---|
| 13F-HR 0001420506-26-002739 | this filing | 2026-11-16 |